Results 51 to 60 of about 2,443 (107)

P-085: THE MORBIDITY AND MORTALITY OF SICKLE CELL DISEASE PATIENTS IN THE HAEMATOLOGY DEPARTMENT OF THE IGNACE DEEN HOSPITAL, CONAKRY HOSPITAL AND UNIVERSITY CENTRE

HemaSphere, 2022
DIAKITE M., GUILAVOGUI F., KANTE A., CONDE A., SYLLA M., TOUNKARA T.   +5 more
doaj   +1 more source

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)

Haematologica, 2018
The purpose of this study was to identify the incidence, causes and impact of non-adherence to oral and subcutaneous chronic treatments for patients with polycythemia vera or essential thrombocythemia.
Ronan Le Calloch, Karine Lacut, Christelle Le Gall-Ianotto, Emmanuel Nowak, Morgane Abiven, Adrian Tempescul, Florence Dalbies, Jean-Richard Eveillard, Valérie Ugo, Stéphane Giraudier, Gaëlle Guillerm, Eric Lippert, Christian Berthou, Jean-Christophe Ianotto   +13 more
doaj   +1 more source

Exploring the needs and resources of children in a haematology-oncology unit

Health SA Gesondheid: Journal of Interdisciplinary Health Sciences, 2011
Too often a child’s body is restored to health in the hospital, but the child is sent home with emotional wounds. This study explored the needs of children in a haematology-oncology unit as well as the resources that could be mobilised in order to ...
Annemarie E. Oberholzer, Elzabe Nel, Chris P.H. Myburgh, Marie Poggenpoel   +3 more
doaj   +1 more source

P-084: INFECTIOUS PROFILE OF SICKLE CELL PATIENTS IN THE HEMATOLOGY DEPARTMENTS OF CONAKRY UNIVERSITY HOSPITAL

HemaSphere, 2022
DIAKITE M., KANTE A., TOFOITA BINTY A., CAMARA F., SAKO F.   +4 more
doaj   +1 more source

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15− cells in early chronic‐phase chronic myeloid leukemia

Molecular Oncology, 2018
Despite the high efficiency of tyrosine kinase inhibitors (TKI), some patients with chronic myeloid leukemia (CML) will display residual disease that can become resistant to treatment, indicating intraclonal heterogeneity in chronic‐phase CML (CP‐CML ...
Stéphanie Maupetit‐Mehouas, Franck Court, Céline Bourgne, Agnès Guerci‐Bresler, Pascale Cony‐Makhoul, Hyacinthe Johnson, Gabriel Etienne, Philippe Rousselot, Denis Guyotat, Alexandre Janel, Eric Hermet, Sandrine Saugues, Juliette Berger, Philippe Arnaud, Marc G. Berger   +14 more
doaj   +1 more source

Distinct Tryptase Gene Copy Number Variations Correlate With Tryptase Levels in a Population‐Based Cohort

Allergy, Volume 81, Issue 4, Page 1277-1280, April 2026.
Yannick Chantran, Simone Choi, Céline Roda, Stéphane Barete, Pierre Hirsch, Olivier Hermine, Laura Polivka, Julien Rossignol, Michel Arock, Fanny Rancière, Isabelle Momas   +10 more
wiley   +1 more source

Pattern of care of prostate cancer patients across the Martinique: results of a population-based study in the Caribbean

BMC Cancer, 2018
Background The French West-Indies rank first for both prostate cancer incidence and mortality rates. Analyzing diagnostic and therapeutic procedures among patients with prostate cancer, using data from a population-based cancer registry, is essential for
Clarisse Joachim, Jacqueline Veronique-Baudin, Stephen Ulric-Gervaise, Jonathan Macni, Thierry Almont, Olivier Pierre-Louis, Lidvine Godaert, Moustapha Drame, Jean-Luc Novella, Karim Farid, Vincent Vinh-Hung, Patrick Escarmant   +11 more
doaj   +1 more source

B01 VENETOCLAX TARGETED THERAPY in AL AMYLOIDOSIS PATIENTS: A RETROSPECTIVE ANALYSIS FROM THE FRENCH AMYLOIDOSIS NETWORK

HemaSphere, 2023
M. Roussel, M. Pirotte, R. Gounot, K. Queru, O. Rizzo, B. Royer, S. Harel, E. Desport, A. Huart, M. Niault, L. Karlin, O. Decaux, T. Chalopin, B. Carpentier, M. Macro, M. Vignon, E. Chalayer, AM. Stoppa, F. Bridoux, A. Jaccard   +19 more
doaj   +1 more source

Posterior reversible encephalopathy syndrome (PRES) and myeloma

Leukemia Research Reports
Posterior reversible encephalopathy syndrome (PRES) has rarely been described in myeloma, but chemotherapy is a known risk factor. We report 3 patients with myeloma who developed PRES, and analyzed them with 13 published cases, mostly women.
Ricardos Ghanem, Sylvie Glaisner, Arthur Bobin, Anne-Marie Ronchetti, Sophie Cereja, Bertrand Joly, Célia Salanoubat, Guillemette Fouquet   +7 more
doaj   +1 more source

Evaluation externe de la qualité de la numération des lymphocytes T-CD4 au laboratoire d'immunologie et hématologie du CHU de Cocody

The Pan African Medical Journal, 2018
INTRODUCTION: Le taux de lymphocytes T-CD4 (LT4) est un paramètre crucial de suivi et de décision thérapeutique au cours de l'infection au Virus de l'Immunodéficience Humaine (VIH). Sa détermination doit être fiable et précise. Pour fournir des résultats
Koffi N’guessan, Yekayo Benedicte Koné, Oppong Richard Yéboah, Amah Patricia Goran-Kouacou, SérYRomuald Dassé   +4 more
doaj   +1 more source